down arrow

iSpecimen, Inc.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US45032V1089
USD
0.49
0.07 (17.03%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.450.51

52 Week

0.394.66
Valuation
Technical
Day's Volume

CASH

329.13 k

Shareholding (Mar 2025)

FII

0.00%

Held by 2 FIIs

DII

96.19%

Held by 4 DIIs

Promoter

0.00%

How big is iSpecimen, Inc.?

22-Jun-2025

As of Jun 18, iSpecimen, Inc. has a market capitalization of 2.47 million and reported net sales of 8.06 million, with a net profit loss of 11.26 million over the latest four quarters. The company's balance sheet shows shareholder's funds of 3.31 million and total assets of 9.35 million.

As of Jun 18, iSpecimen, Inc. has a market capitalization of 2.47 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 8.06 million for the latest four quarters. However, it also experienced a net profit loss of 11.26 million during the same period.<BR><BR>As of Dec 24, the company's balance sheet shows shareholder's funds of 3.31 million and total assets amounting to 9.35 million.

Read More

What does iSpecimen, Inc. do?

22-Jun-2025

iSpecimen, Inc. is a micro-cap company in the miscellaneous industry, reporting net sales of $1 million and a net loss of $2 million as of March 2025. It has a market cap of $2.47 million and key metrics indicating significant financial challenges.

Overview: <BR>iSpecimen, Inc. operates in the miscellaneous industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 2.47 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.44 <BR>Return on Equity: -674.50% <BR>Price to Book: 1.48<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Should I buy, sell or hold iSpecimen, Inc.?

22-Jun-2025

Is iSpecimen, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, iSpecimen, Inc. has shifted to a neutral trend with mixed technical indicators, showing a significant yearly underperformance of -71.92% compared to the S&P 500's 17.14%, despite a recent short-term gain of 17.42%.

As of 11 September 2025, the technical trend for iSpecimen, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD and KST are mildly bullish, while the monthly KST is bearish, indicating some divergence in momentum. Moving averages on the daily timeframe are mildly bearish, which adds to the uncertainty. The Bollinger Bands show a mildly bullish signal on the weekly but are sideways on the monthly. <BR><BR>In terms of performance, iSpecimen has significantly underperformed the S&P 500 over the year, with a return of -71.92% compared to the S&P's 17.14%. However, it has shown strong short-term gains, with a 1-week return of 17.42% versus the S&P's 1.05%. Overall, the technical indicators suggest a cautious approach given the mixed signals and the recent trend change.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses. Due to this company has reported negative ROE
2

Poor long term growth as Net Sales has grown by an annual rate of 2.59% over the last 5 years

 
3

Negative results in Jun 25

4

Risky - Negative EBITDA

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 6 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.54

stock-summary
Return on Equity

-1,019.23%

stock-summary
Price to Book

6.14

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.65%
0%
-27.65%
6 Months
-61.89%
0%
-61.89%
1 Year
-88.26%
0%
-88.26%
2 Years
-95.52%
0%
-95.52%
3 Years
-68.24%
0%
-68.24%
4 Years
-99.82%
0%
-99.82%
5 Years
0%
0%
0.0%

iSpecimen, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is iSpecimen, Inc. technically bullish or bearish?

As of 11 September 2025, the technical trend for iSpecimen, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD and KST are mildly bullish, while the monthly KST is bearish, indicating some divergence in momentum. Moving averages on the daily timeframe are mildly bearish, which adds to the uncertainty. The Bollinger Bands show a mildly bullish signal on the weekly but are sideways on the monthly. In terms of performance, iSpecimen has significantly underperformed the S&P 500 over the year, with a return of -71.92% compared to the S&P's 17.14%. However, it has shown strong short-term gains, with a 1-week return of 17.42% versus the S&P's 1.05%. Overall, the technical indicators suggest a cautious approach given the mixed signals and the recent trend change....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.59%
EBIT Growth (5y)
-210.80%
EBIT to Interest (avg)
-8.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
2.14
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.47%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.89
EV to EBIT
-0.21
EV to EBITDA
-0.26
EV to Capital Employed
2.41
EV to Sales
0.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1136.59%
ROE (Latest)
-674.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 3 Schemes (3.81%)

Foreign Institutions

Held by 2 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -36.36% vs -26.67% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 41.18% vs 71.67% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "1.10",
          "chgp": "-36.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.40",
          "val2": "-1.20",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.00",
          "val2": "-1.70",
          "chgp": "41.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,554.10%",
          "val2": "-1,549.30%",
          "chgp": "-100.48%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.06% vs -4.81% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.61% vs -8.82% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.30",
          "val2": "9.90",
          "chgp": "-6.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.10",
          "val2": "-9.10",
          "chgp": "-10.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-12.50",
          "val2": "-11.10",
          "chgp": "-12.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,334.70%",
          "val2": "-1,125.00%",
          "chgp": "-20.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.70
1.10
-36.36%
Operating Profit (PBDIT) excl Other Income
-1.40
-1.20
-16.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.00
-1.70
41.18%
Operating Profit Margin (Excl OI)
-2,554.10%
-1,549.30%
-100.48%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -36.36% vs -26.67% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 41.18% vs 71.67% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
9.30
9.90
-6.06%
Operating Profit (PBDIT) excl Other Income
-10.10
-9.10
-10.99%
Interest
0.20
0.00
Exceptional Items
-0.30
0.00
Consolidate Net Profit
-12.50
-11.10
-12.61%
Operating Profit Margin (Excl OI)
-1,334.70%
-1,125.00%
-20.97%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -6.06% vs -4.81% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -12.61% vs -8.82% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About iSpecimen, Inc. stock-summary
stock-summary
iSpecimen, Inc.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."